Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,675.82
(
-0.60%
)
US TECH 100
24,032.40
(
-0.41%
)
Dow Jones
46,570.71
(
-0.90%
)
Brent Oil
105.41
(
4.72%
)
Bitcoin
71,287.74
(
-3.59%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 107952

Wednesday, 11/03/2010 4:58:37 AM

Wednesday, November 03, 2010 4:58:37 AM

Post# of 257253
Low-volume Copaxone—I expect the 1/1/11 PDUFA date will be extended to allow the FDA to review the newly submitted data.

I'm not going to post the rest of the details and comments as I don't wish to provoke more anti Teva and anti Israeli discussions. I think we already had too much of those on this board.

Please post the rest of what you wanted to post. The objectionable comments you refer to have already been removed from the board. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now